nodes	percent_of_prediction	percent_of_DWPC	metapath
Rifabutin—CYP3A4—Ezetimibe—atherosclerosis	0.0622	0.211	CbGbCtD
Rifabutin—CYP3A4—Rosuvastatin—atherosclerosis	0.0622	0.211	CbGbCtD
Rifabutin—CYP3A4—Simvastatin—atherosclerosis	0.0579	0.196	CbGbCtD
Rifabutin—CYP3A4—Lovastatin—atherosclerosis	0.0566	0.192	CbGbCtD
Rifabutin—CYP3A4—Pravastatin—atherosclerosis	0.0566	0.192	CbGbCtD
Rifabutin—HSP90AA1—endothelium—atherosclerosis	0.0128	0.178	CbGeAlD
Rifabutin—HSP90AA1—blood vessel—atherosclerosis	0.0118	0.164	CbGeAlD
Rifabutin—Myositis—Rosuvastatin—atherosclerosis	0.0095	0.0319	CcSEcCtD
Rifabutin—HSP90B1—connective tissue—atherosclerosis	0.00829	0.115	CbGeAlD
Rifabutin—HSP90B1—cardiovascular system—atherosclerosis	0.00722	0.1	CbGeAlD
Rifabutin—HSP90B1—adipose tissue—atherosclerosis	0.00636	0.0883	CbGeAlD
Rifabutin—HSP90AA1—connective tissue—atherosclerosis	0.00606	0.0842	CbGeAlD
Rifabutin—Gastrointestinal symptom NOS—Niacin—atherosclerosis	0.00577	0.0194	CcSEcCtD
Rifabutin—HSP90AA1—cardiovascular system—atherosclerosis	0.00528	0.0732	CbGeAlD
Rifabutin—Hepatic enzyme increased—Rosuvastatin—atherosclerosis	0.00493	0.0166	CcSEcCtD
Rifabutin—HSP90AA1—adipose tissue—atherosclerosis	0.00465	0.0646	CbGeAlD
Rifabutin—HSP90B1—liver—atherosclerosis	0.00446	0.0619	CbGeAlD
Rifabutin—Phosphatase alkaline increased—Lovastatin—atherosclerosis	0.00395	0.0133	CcSEcCtD
Rifabutin—Phosphatase alkaline increased—Ezetimibe—atherosclerosis	0.00388	0.013	CcSEcCtD
Rifabutin—Skin discolouration—Niacin—atherosclerosis	0.00376	0.0126	CcSEcCtD
Rifabutin—Phosphatase alkaline increased—Simvastatin—atherosclerosis	0.0037	0.0124	CcSEcCtD
Rifabutin—Phosphatase alkaline increased—Pravastatin—atherosclerosis	0.00334	0.0112	CcSEcCtD
Rifabutin—Eructation—Niacin—atherosclerosis	0.00333	0.0112	CcSEcCtD
Rifabutin—Blood alkaline phosphatase increased—Lovastatin—atherosclerosis	0.0033	0.0111	CcSEcCtD
Rifabutin—HSP90AA1—liver—atherosclerosis	0.00326	0.0453	CbGeAlD
Rifabutin—Blood alkaline phosphatase increased—Ezetimibe—atherosclerosis	0.00323	0.0109	CcSEcCtD
Rifabutin—Blood alkaline phosphatase increased—Simvastatin—atherosclerosis	0.00308	0.0104	CcSEcCtD
Rifabutin—Blood alkaline phosphatase increased—Pravastatin—atherosclerosis	0.00279	0.00936	CcSEcCtD
Rifabutin—Jaundice—Rosuvastatin—atherosclerosis	0.00254	0.00854	CcSEcCtD
Rifabutin—Aspartate aminotransferase increased—Ezetimibe—atherosclerosis	0.00253	0.00851	CcSEcCtD
Rifabutin—Alanine aminotransferase increased—Ezetimibe—atherosclerosis	0.00248	0.00833	CcSEcCtD
Rifabutin—Hepatobiliary disease—Rosuvastatin—atherosclerosis	0.00247	0.00828	CcSEcCtD
Rifabutin—Eosinophilia—Lovastatin—atherosclerosis	0.00245	0.00824	CcSEcCtD
Rifabutin—Eosinophilia—Ezetimibe—atherosclerosis	0.00241	0.00808	CcSEcCtD
Rifabutin—Hepatitis—Rosuvastatin—atherosclerosis	0.00234	0.00786	CcSEcCtD
Rifabutin—Eosinophilia—Simvastatin—atherosclerosis	0.0023	0.00771	CcSEcCtD
Rifabutin—Alanine aminotransferase increased—Pravastatin—atherosclerosis	0.00214	0.00718	CcSEcCtD
Rifabutin—Jaundice—Ezetimibe—atherosclerosis	0.00211	0.00709	CcSEcCtD
Rifabutin—Eosinophilia—Pravastatin—atherosclerosis	0.00208	0.00697	CcSEcCtD
Rifabutin—Hepatobiliary disease—Ezetimibe—atherosclerosis	0.00205	0.00688	CcSEcCtD
Rifabutin—Jaundice—Simvastatin—atherosclerosis	0.00201	0.00677	CcSEcCtD
Rifabutin—Flatulence—Rosuvastatin—atherosclerosis	0.00201	0.00674	CcSEcCtD
Rifabutin—Hepatitis—Lovastatin—atherosclerosis	0.00198	0.00666	CcSEcCtD
Rifabutin—Hepatitis—Ezetimibe—atherosclerosis	0.00195	0.00653	CcSEcCtD
Rifabutin—Connective tissue disorder—Ezetimibe—atherosclerosis	0.00191	0.00642	CcSEcCtD
Rifabutin—Hepatitis—Simvastatin—atherosclerosis	0.00186	0.00623	CcSEcCtD
Rifabutin—Jaundice—Niacin—atherosclerosis	0.00185	0.00621	CcSEcCtD
Rifabutin—Jaundice—Pravastatin—atherosclerosis	0.00182	0.00612	CcSEcCtD
Rifabutin—Immune system disorder—Ezetimibe—atherosclerosis	0.00176	0.0059	CcSEcCtD
Rifabutin—Arthralgia—Rosuvastatin—atherosclerosis	0.00173	0.00583	CcSEcCtD
Rifabutin—Myalgia—Rosuvastatin—atherosclerosis	0.00173	0.00583	CcSEcCtD
Rifabutin—Hepatitis—Niacin—atherosclerosis	0.0017	0.00572	CcSEcCtD
Rifabutin—Flatulence—Lovastatin—atherosclerosis	0.0017	0.00571	CcSEcCtD
Rifabutin—Dysgeusia—Lovastatin—atherosclerosis	0.00169	0.00568	CcSEcCtD
Rifabutin—Hepatitis—Pravastatin—atherosclerosis	0.00168	0.00563	CcSEcCtD
Rifabutin—Confusional state—Rosuvastatin—atherosclerosis	0.00168	0.00563	CcSEcCtD
Rifabutin—Flatulence—Ezetimibe—atherosclerosis	0.00167	0.00561	CcSEcCtD
Rifabutin—Thrombocytopenia—Rosuvastatin—atherosclerosis	0.00163	0.00547	CcSEcCtD
Rifabutin—Eye disorder—Niacin—atherosclerosis	0.00159	0.00535	CcSEcCtD
Rifabutin—Flatulence—Simvastatin—atherosclerosis	0.00159	0.00535	CcSEcCtD
Rifabutin—Dysgeusia—Simvastatin—atherosclerosis	0.00158	0.00531	CcSEcCtD
Rifabutin—Anaemia—Ezetimibe—atherosclerosis	0.00157	0.00526	CcSEcCtD
Rifabutin—Leukopenia—Lovastatin—atherosclerosis	0.00155	0.00519	CcSEcCtD
Rifabutin—Musculoskeletal discomfort—Rosuvastatin—atherosclerosis	0.00152	0.00509	CcSEcCtD
Rifabutin—Insomnia—Rosuvastatin—atherosclerosis	0.0015	0.00505	CcSEcCtD
Rifabutin—Paraesthesia—Rosuvastatin—atherosclerosis	0.00149	0.00501	CcSEcCtD
Rifabutin—Anaemia—Simvastatin—atherosclerosis	0.00149	0.00501	CcSEcCtD
Rifabutin—Arthralgia—Lovastatin—atherosclerosis	0.00147	0.00494	CcSEcCtD
Rifabutin—Myalgia—Lovastatin—atherosclerosis	0.00147	0.00494	CcSEcCtD
Rifabutin—Chest pain—Lovastatin—atherosclerosis	0.00147	0.00494	CcSEcCtD
Rifabutin—Dyspepsia—Rosuvastatin—atherosclerosis	0.00146	0.00492	CcSEcCtD
Rifabutin—Flatulence—Niacin—atherosclerosis	0.00146	0.00491	CcSEcCtD
Rifabutin—Leukopenia—Simvastatin—atherosclerosis	0.00145	0.00486	CcSEcCtD
Rifabutin—Myalgia—Ezetimibe—atherosclerosis	0.00144	0.00484	CcSEcCtD
Rifabutin—Arthralgia—Ezetimibe—atherosclerosis	0.00144	0.00484	CcSEcCtD
Rifabutin—Chest pain—Ezetimibe—atherosclerosis	0.00144	0.00484	CcSEcCtD
Rifabutin—Flatulence—Pravastatin—atherosclerosis	0.00144	0.00483	CcSEcCtD
Rifabutin—Unspecified disorder of skin and subcutaneous tissue—Ezetimibe—atherosclerosis	0.00143	0.00481	CcSEcCtD
Rifabutin—Dysgeusia—Pravastatin—atherosclerosis	0.00143	0.0048	CcSEcCtD
Rifabutin—Pain—Rosuvastatin—atherosclerosis	0.00142	0.00478	CcSEcCtD
Rifabutin—Confusional state—Lovastatin—atherosclerosis	0.00142	0.00477	CcSEcCtD
Rifabutin—Confusional state—Ezetimibe—atherosclerosis	0.00139	0.00468	CcSEcCtD
Rifabutin—Thrombocytopenia—Lovastatin—atherosclerosis	0.00138	0.00463	CcSEcCtD
Rifabutin—Arthralgia—Simvastatin—atherosclerosis	0.00138	0.00462	CcSEcCtD
Rifabutin—Chest pain—Simvastatin—atherosclerosis	0.00138	0.00462	CcSEcCtD
Rifabutin—Myalgia—Simvastatin—atherosclerosis	0.00138	0.00462	CcSEcCtD
Rifabutin—Feeling abnormal—Rosuvastatin—atherosclerosis	0.00137	0.0046	CcSEcCtD
Rifabutin—Gastrointestinal pain—Rosuvastatin—atherosclerosis	0.00136	0.00457	CcSEcCtD
Rifabutin—Thrombocytopenia—Ezetimibe—atherosclerosis	0.00135	0.00455	CcSEcCtD
Rifabutin—Anaemia—Pravastatin—atherosclerosis	0.00135	0.00453	CcSEcCtD
Rifabutin—Anorexia—Lovastatin—atherosclerosis	0.00134	0.00451	CcSEcCtD
Rifabutin—Skin disorder—Ezetimibe—atherosclerosis	0.00134	0.00451	CcSEcCtD
Rifabutin—Confusional state—Simvastatin—atherosclerosis	0.00133	0.00446	CcSEcCtD
Rifabutin—Leukopenia—Niacin—atherosclerosis	0.00133	0.00446	CcSEcCtD
Rifabutin—Abdominal pain—Rosuvastatin—atherosclerosis	0.00131	0.00442	CcSEcCtD
Rifabutin—Leukopenia—Pravastatin—atherosclerosis	0.00131	0.00439	CcSEcCtD
Rifabutin—Thrombocytopenia—Simvastatin—atherosclerosis	0.00129	0.00433	CcSEcCtD
Rifabutin—Musculoskeletal discomfort—Lovastatin—atherosclerosis	0.00128	0.00431	CcSEcCtD
Rifabutin—Insomnia—Lovastatin—atherosclerosis	0.00127	0.00428	CcSEcCtD
Rifabutin—Paraesthesia—Lovastatin—atherosclerosis	0.00127	0.00425	CcSEcCtD
Rifabutin—Myalgia—Niacin—atherosclerosis	0.00126	0.00424	CcSEcCtD
Rifabutin—Arthralgia—Niacin—atherosclerosis	0.00126	0.00424	CcSEcCtD
Rifabutin—Musculoskeletal discomfort—Ezetimibe—atherosclerosis	0.00126	0.00423	CcSEcCtD
Rifabutin—Anorexia—Simvastatin—atherosclerosis	0.00126	0.00422	CcSEcCtD
Rifabutin—Dyspnoea—Lovastatin—atherosclerosis	0.00126	0.00422	CcSEcCtD
Rifabutin—Unspecified disorder of skin and subcutaneous tissue—Niacin—atherosclerosis	0.00125	0.00421	CcSEcCtD
Rifabutin—Insomnia—Ezetimibe—atherosclerosis	0.00125	0.0042	CcSEcCtD
Rifabutin—Chest pain—Pravastatin—atherosclerosis	0.00124	0.00418	CcSEcCtD
Rifabutin—Myalgia—Pravastatin—atherosclerosis	0.00124	0.00418	CcSEcCtD
Rifabutin—Arthralgia—Pravastatin—atherosclerosis	0.00124	0.00418	CcSEcCtD
Rifabutin—Paraesthesia—Ezetimibe—atherosclerosis	0.00124	0.00417	CcSEcCtD
Rifabutin—Dyspepsia—Lovastatin—atherosclerosis	0.00124	0.00417	CcSEcCtD
Rifabutin—Dyspnoea—Ezetimibe—atherosclerosis	0.00123	0.00414	CcSEcCtD
Rifabutin—Hypersensitivity—Rosuvastatin—atherosclerosis	0.00123	0.00411	CcSEcCtD
Rifabutin—Decreased appetite—Lovastatin—atherosclerosis	0.00123	0.00411	CcSEcCtD
Rifabutin—Dyspepsia—Ezetimibe—atherosclerosis	0.00122	0.00409	CcSEcCtD
Rifabutin—Pain—Lovastatin—atherosclerosis	0.00121	0.00405	CcSEcCtD
Rifabutin—Confusional state—Pravastatin—atherosclerosis	0.0012	0.00404	CcSEcCtD
Rifabutin—Decreased appetite—Ezetimibe—atherosclerosis	0.0012	0.00404	CcSEcCtD
Rifabutin—Musculoskeletal discomfort—Simvastatin—atherosclerosis	0.0012	0.00403	CcSEcCtD
Rifabutin—Gastrointestinal disorder—Ezetimibe—atherosclerosis	0.00119	0.00401	CcSEcCtD
Rifabutin—Asthenia—Rosuvastatin—atherosclerosis	0.00119	0.00401	CcSEcCtD
Rifabutin—Insomnia—Simvastatin—atherosclerosis	0.00119	0.004	CcSEcCtD
Rifabutin—Shock—Niacin—atherosclerosis	0.00119	0.004	CcSEcCtD
Rifabutin—Paraesthesia—Simvastatin—atherosclerosis	0.00118	0.00398	CcSEcCtD
Rifabutin—Pain—Ezetimibe—atherosclerosis	0.00118	0.00397	CcSEcCtD
Rifabutin—Pruritus—Rosuvastatin—atherosclerosis	0.00118	0.00395	CcSEcCtD
Rifabutin—Skin disorder—Niacin—atherosclerosis	0.00118	0.00395	CcSEcCtD
Rifabutin—Dyspnoea—Simvastatin—atherosclerosis	0.00118	0.00395	CcSEcCtD
Rifabutin—Thrombocytopenia—Pravastatin—atherosclerosis	0.00117	0.00392	CcSEcCtD
Rifabutin—Feeling abnormal—Lovastatin—atherosclerosis	0.00116	0.0039	CcSEcCtD
Rifabutin—Dyspepsia—Simvastatin—atherosclerosis	0.00116	0.0039	CcSEcCtD
Rifabutin—Anorexia—Niacin—atherosclerosis	0.00115	0.00387	CcSEcCtD
Rifabutin—Gastrointestinal pain—Lovastatin—atherosclerosis	0.00115	0.00387	CcSEcCtD
Rifabutin—Decreased appetite—Simvastatin—atherosclerosis	0.00115	0.00385	CcSEcCtD
Rifabutin—Feeling abnormal—Ezetimibe—atherosclerosis	0.00114	0.00383	CcSEcCtD
Rifabutin—Gastrointestinal disorder—Simvastatin—atherosclerosis	0.00114	0.00382	CcSEcCtD
Rifabutin—Diarrhoea—Rosuvastatin—atherosclerosis	0.00114	0.00382	CcSEcCtD
Rifabutin—Anorexia—Pravastatin—atherosclerosis	0.00114	0.00382	CcSEcCtD
Rifabutin—Gastrointestinal pain—Ezetimibe—atherosclerosis	0.00113	0.0038	CcSEcCtD
Rifabutin—Pain—Simvastatin—atherosclerosis	0.00113	0.00379	CcSEcCtD
Rifabutin—Body temperature increased—Lovastatin—atherosclerosis	0.00111	0.00374	CcSEcCtD
Rifabutin—Abdominal pain—Lovastatin—atherosclerosis	0.00111	0.00374	CcSEcCtD
Rifabutin—Musculoskeletal discomfort—Niacin—atherosclerosis	0.0011	0.0037	CcSEcCtD
Rifabutin—Insomnia—Niacin—atherosclerosis	0.00109	0.00368	CcSEcCtD
Rifabutin—Abdominal pain—Ezetimibe—atherosclerosis	0.00109	0.00367	CcSEcCtD
Rifabutin—Body temperature increased—Ezetimibe—atherosclerosis	0.00109	0.00367	CcSEcCtD
Rifabutin—Paraesthesia—Niacin—atherosclerosis	0.00109	0.00365	CcSEcCtD
Rifabutin—Feeling abnormal—Simvastatin—atherosclerosis	0.00109	0.00365	CcSEcCtD
Rifabutin—Musculoskeletal discomfort—Pravastatin—atherosclerosis	0.00109	0.00365	CcSEcCtD
Rifabutin—Dyspnoea—Niacin—atherosclerosis	0.00108	0.00362	CcSEcCtD
Rifabutin—Gastrointestinal pain—Simvastatin—atherosclerosis	0.00108	0.00362	CcSEcCtD
Rifabutin—Insomnia—Pravastatin—atherosclerosis	0.00108	0.00362	CcSEcCtD
Rifabutin—Paraesthesia—Pravastatin—atherosclerosis	0.00107	0.00359	CcSEcCtD
Rifabutin—Dyspepsia—Niacin—atherosclerosis	0.00107	0.00358	CcSEcCtD
Rifabutin—Dyspnoea—Pravastatin—atherosclerosis	0.00106	0.00357	CcSEcCtD
Rifabutin—CYP1A2—liver—atherosclerosis	0.00105	0.0146	CbGeAlD
Rifabutin—Decreased appetite—Niacin—atherosclerosis	0.00105	0.00353	CcSEcCtD
Rifabutin—Dyspepsia—Pravastatin—atherosclerosis	0.00105	0.00352	CcSEcCtD
Rifabutin—Rash—Rosuvastatin—atherosclerosis	0.00105	0.00352	CcSEcCtD
Rifabutin—Dermatitis—Rosuvastatin—atherosclerosis	0.00105	0.00352	CcSEcCtD
Rifabutin—Gastrointestinal disorder—Niacin—atherosclerosis	0.00105	0.00351	CcSEcCtD
Rifabutin—Abdominal pain—Simvastatin—atherosclerosis	0.00104	0.0035	CcSEcCtD
Rifabutin—Body temperature increased—Simvastatin—atherosclerosis	0.00104	0.0035	CcSEcCtD
Rifabutin—Headache—Rosuvastatin—atherosclerosis	0.00104	0.0035	CcSEcCtD
Rifabutin—Hypersensitivity—Lovastatin—atherosclerosis	0.00104	0.00349	CcSEcCtD
Rifabutin—Decreased appetite—Pravastatin—atherosclerosis	0.00104	0.00348	CcSEcCtD
Rifabutin—Pain—Niacin—atherosclerosis	0.00104	0.00348	CcSEcCtD
Rifabutin—Pain—Pravastatin—atherosclerosis	0.00102	0.00342	CcSEcCtD
Rifabutin—Hypersensitivity—Ezetimibe—atherosclerosis	0.00102	0.00342	CcSEcCtD
Rifabutin—Asthenia—Lovastatin—atherosclerosis	0.00101	0.0034	CcSEcCtD
Rifabutin—Pruritus—Lovastatin—atherosclerosis	0.000997	0.00335	CcSEcCtD
Rifabutin—Asthenia—Ezetimibe—atherosclerosis	0.000992	0.00333	CcSEcCtD
Rifabutin—Gastrointestinal pain—Niacin—atherosclerosis	0.00099	0.00332	CcSEcCtD
Rifabutin—Nausea—Rosuvastatin—atherosclerosis	0.000988	0.00332	CcSEcCtD
Rifabutin—Feeling abnormal—Pravastatin—atherosclerosis	0.000982	0.0033	CcSEcCtD
Rifabutin—Pruritus—Ezetimibe—atherosclerosis	0.000978	0.00328	CcSEcCtD
Rifabutin—Gastrointestinal pain—Pravastatin—atherosclerosis	0.000975	0.00327	CcSEcCtD
Rifabutin—Hypersensitivity—Simvastatin—atherosclerosis	0.000971	0.00326	CcSEcCtD
Rifabutin—Diarrhoea—Lovastatin—atherosclerosis	0.000964	0.00324	CcSEcCtD
Rifabutin—Abdominal pain—Niacin—atherosclerosis	0.000957	0.00321	CcSEcCtD
Rifabutin—Body temperature increased—Niacin—atherosclerosis	0.000957	0.00321	CcSEcCtD
Rifabutin—Asthenia—Simvastatin—atherosclerosis	0.000946	0.00318	CcSEcCtD
Rifabutin—Diarrhoea—Ezetimibe—atherosclerosis	0.000946	0.00318	CcSEcCtD
Rifabutin—Abdominal pain—Pravastatin—atherosclerosis	0.000942	0.00316	CcSEcCtD
Rifabutin—Body temperature increased—Pravastatin—atherosclerosis	0.000942	0.00316	CcSEcCtD
Rifabutin—Pruritus—Simvastatin—atherosclerosis	0.000933	0.00313	CcSEcCtD
Rifabutin—Diarrhoea—Simvastatin—atherosclerosis	0.000902	0.00303	CcSEcCtD
Rifabutin—Vomiting—Lovastatin—atherosclerosis	0.000896	0.00301	CcSEcCtD
Rifabutin—Hypersensitivity—Niacin—atherosclerosis	0.000892	0.00299	CcSEcCtD
Rifabutin—Rash—Lovastatin—atherosclerosis	0.000889	0.00298	CcSEcCtD
Rifabutin—Dermatitis—Lovastatin—atherosclerosis	0.000888	0.00298	CcSEcCtD
Rifabutin—Headache—Lovastatin—atherosclerosis	0.000883	0.00297	CcSEcCtD
Rifabutin—Vomiting—Ezetimibe—atherosclerosis	0.000879	0.00295	CcSEcCtD
Rifabutin—Hypersensitivity—Pravastatin—atherosclerosis	0.000878	0.00295	CcSEcCtD
Rifabutin—Rash—Ezetimibe—atherosclerosis	0.000872	0.00293	CcSEcCtD
Rifabutin—Dermatitis—Ezetimibe—atherosclerosis	0.000871	0.00292	CcSEcCtD
Rifabutin—Asthenia—Niacin—atherosclerosis	0.000869	0.00292	CcSEcCtD
Rifabutin—Headache—Ezetimibe—atherosclerosis	0.000866	0.00291	CcSEcCtD
Rifabutin—Pruritus—Niacin—atherosclerosis	0.000856	0.00288	CcSEcCtD
Rifabutin—Asthenia—Pravastatin—atherosclerosis	0.000855	0.00287	CcSEcCtD
Rifabutin—Pruritus—Pravastatin—atherosclerosis	0.000843	0.00283	CcSEcCtD
Rifabutin—Vomiting—Simvastatin—atherosclerosis	0.000838	0.00281	CcSEcCtD
Rifabutin—Nausea—Lovastatin—atherosclerosis	0.000837	0.00281	CcSEcCtD
Rifabutin—Rash—Simvastatin—atherosclerosis	0.000831	0.00279	CcSEcCtD
Rifabutin—Dermatitis—Simvastatin—atherosclerosis	0.00083	0.00279	CcSEcCtD
Rifabutin—Diarrhoea—Niacin—atherosclerosis	0.000828	0.00278	CcSEcCtD
Rifabutin—Headache—Simvastatin—atherosclerosis	0.000826	0.00277	CcSEcCtD
Rifabutin—Nausea—Ezetimibe—atherosclerosis	0.000821	0.00276	CcSEcCtD
Rifabutin—Diarrhoea—Pravastatin—atherosclerosis	0.000816	0.00274	CcSEcCtD
Rifabutin—Nausea—Simvastatin—atherosclerosis	0.000783	0.00263	CcSEcCtD
Rifabutin—Vomiting—Niacin—atherosclerosis	0.00077	0.00258	CcSEcCtD
Rifabutin—CYP3A4—liver—atherosclerosis	0.000764	0.0106	CbGeAlD
Rifabutin—Rash—Niacin—atherosclerosis	0.000763	0.00256	CcSEcCtD
Rifabutin—Dermatitis—Niacin—atherosclerosis	0.000763	0.00256	CcSEcCtD
Rifabutin—Headache—Niacin—atherosclerosis	0.000758	0.00255	CcSEcCtD
Rifabutin—Vomiting—Pravastatin—atherosclerosis	0.000758	0.00254	CcSEcCtD
Rifabutin—Rash—Pravastatin—atherosclerosis	0.000752	0.00252	CcSEcCtD
Rifabutin—Dermatitis—Pravastatin—atherosclerosis	0.000751	0.00252	CcSEcCtD
Rifabutin—Headache—Pravastatin—atherosclerosis	0.000747	0.00251	CcSEcCtD
Rifabutin—Nausea—Niacin—atherosclerosis	0.000719	0.00241	CcSEcCtD
Rifabutin—Nausea—Pravastatin—atherosclerosis	0.000708	0.00238	CcSEcCtD
Rifabutin—HSP90AA1—Immune System—CD40LG—atherosclerosis	0.000108	0.000324	CbGpPWpGaD
Rifabutin—HSP90AA1—Cellular responses to stress—IL6—atherosclerosis	0.000107	0.000319	CbGpPWpGaD
Rifabutin—CYP1A2—Metabolism of lipids and lipoproteins—ABCG1—atherosclerosis	0.000106	0.000316	CbGpPWpGaD
Rifabutin—HSP90AA1—Metabolism—ABCA1—atherosclerosis	0.000105	0.000313	CbGpPWpGaD
Rifabutin—HSP90AA1—Immune System—AGER—atherosclerosis	0.000105	0.000312	CbGpPWpGaD
Rifabutin—HSP90AA1—Developmental Biology—MMP9—atherosclerosis	0.000104	0.000311	CbGpPWpGaD
Rifabutin—HSP90AA1—Signaling Pathways—NCF1—atherosclerosis	0.000104	0.000311	CbGpPWpGaD
Rifabutin—HSP90AA1—Immune System—PRKCG—atherosclerosis	0.000103	0.000309	CbGpPWpGaD
Rifabutin—HSP90AA1—Developmental Biology—NFKB1—atherosclerosis	0.000103	0.000308	CbGpPWpGaD
Rifabutin—CYP1A2—Biological oxidations—GSTM1—atherosclerosis	0.000103	0.000308	CbGpPWpGaD
Rifabutin—HSP90AA1—Disease—APOB—atherosclerosis	0.000103	0.000308	CbGpPWpGaD
Rifabutin—CYP1A2—Metapathway biotransformation—GSTM1—atherosclerosis	0.000102	0.000304	CbGpPWpGaD
Rifabutin—HSP90AA1—Immune System—CD36—atherosclerosis	0.000101	0.000302	CbGpPWpGaD
Rifabutin—CYP1A2—Metabolism of lipids and lipoproteins—FABP4—atherosclerosis	9.94e-05	0.000297	CbGpPWpGaD
Rifabutin—CYP1A2—Metabolism of lipids and lipoproteins—LCAT—atherosclerosis	9.94e-05	0.000297	CbGpPWpGaD
Rifabutin—HSP90AA1—Signaling Pathways—CCR2—atherosclerosis	9.83e-05	0.000294	CbGpPWpGaD
Rifabutin—HSP90AA1—Signaling Pathways—EDNRA—atherosclerosis	9.83e-05	0.000294	CbGpPWpGaD
Rifabutin—HSP90AA1—Disease—LPL—atherosclerosis	9.82e-05	0.000294	CbGpPWpGaD
Rifabutin—HSP90AA1—Signaling Pathways—CYBA—atherosclerosis	9.79e-05	0.000293	CbGpPWpGaD
Rifabutin—CYP1A2—Metabolism of lipids and lipoproteins—APOA4—atherosclerosis	9.76e-05	0.000292	CbGpPWpGaD
Rifabutin—CYP1A2—Metabolism of lipids and lipoproteins—CYP7A1—atherosclerosis	9.59e-05	0.000287	CbGpPWpGaD
Rifabutin—HSP90AA1—Signaling Pathways—PLAT—atherosclerosis	9.58e-05	0.000286	CbGpPWpGaD
Rifabutin—HSP90AA1—Signaling Pathways—PARP1—atherosclerosis	9.58e-05	0.000286	CbGpPWpGaD
Rifabutin—HSP90AA1—Signaling Pathways—GHRL—atherosclerosis	9.58e-05	0.000286	CbGpPWpGaD
Rifabutin—HSP90AA1—Disease—PRKCG—atherosclerosis	9.55e-05	0.000285	CbGpPWpGaD
Rifabutin—HSP90AA1—Developmental Biology—VEGFA—atherosclerosis	9.36e-05	0.00028	CbGpPWpGaD
Rifabutin—HSP90AA1—Immune System—PDGFB—atherosclerosis	9.32e-05	0.000279	CbGpPWpGaD
Rifabutin—HSP90AA1—Developmental Biology—STAT3—atherosclerosis	9.26e-05	0.000277	CbGpPWpGaD
Rifabutin—HSP90AA1—Cell Cycle, Mitotic—MAPK3—atherosclerosis	9.16e-05	0.000274	CbGpPWpGaD
Rifabutin—HSP90AA1—Immune System—CRP—atherosclerosis	9.11e-05	0.000272	CbGpPWpGaD
Rifabutin—HSP90AA1—Innate Immune System—NFKB1—atherosclerosis	9.11e-05	0.000272	CbGpPWpGaD
Rifabutin—HSP90AA1—Axon guidance—IL6—atherosclerosis	9.07e-05	0.000271	CbGpPWpGaD
Rifabutin—HSP90AA1—Metabolism—HMOX1—atherosclerosis	8.99e-05	0.000269	CbGpPWpGaD
Rifabutin—HSP90AA1—Innate Immune System—MAPK8—atherosclerosis	8.95e-05	0.000268	CbGpPWpGaD
Rifabutin—CYP1A2—Metabolism of lipids and lipoproteins—CYP27A1—atherosclerosis	8.86e-05	0.000265	CbGpPWpGaD
Rifabutin—HSP90AA1—Developmental Biology—MAPK3—atherosclerosis	8.85e-05	0.000265	CbGpPWpGaD
Rifabutin—HSP90AA1—Disease—MTHFR—atherosclerosis	8.84e-05	0.000264	CbGpPWpGaD
Rifabutin—HSP90AA1—Immune System—TLR4—atherosclerosis	8.74e-05	0.000261	CbGpPWpGaD
Rifabutin—HSP90AA1—Metabolism—APOB—atherosclerosis	8.61e-05	0.000258	CbGpPWpGaD
Rifabutin—HSP90AA1—Disease—PDGFB—atherosclerosis	8.61e-05	0.000257	CbGpPWpGaD
Rifabutin—HSP90AA1—Developmental Biology—TGFB1—atherosclerosis	8.59e-05	0.000257	CbGpPWpGaD
Rifabutin—HSP90B1—Immune System—IL6—atherosclerosis	8.53e-05	0.000255	CbGpPWpGaD
Rifabutin—HSP90AA1—Signaling Pathways—KNG1—atherosclerosis	8.41e-05	0.000251	CbGpPWpGaD
Rifabutin—CYP1A2—Metabolism of lipids and lipoproteins—ALOX5AP—atherosclerosis	8.4e-05	0.000251	CbGpPWpGaD
Rifabutin—CYP1A2—Metabolism of lipids and lipoproteins—ALOX15—atherosclerosis	8.4e-05	0.000251	CbGpPWpGaD
Rifabutin—CYP1A2—Metabolism of lipids and lipoproteins—APOA2—atherosclerosis	8.4e-05	0.000251	CbGpPWpGaD
Rifabutin—CYP1A2—Metabolism of lipids and lipoproteins—PLA2G2A—atherosclerosis	8.4e-05	0.000251	CbGpPWpGaD
Rifabutin—HSP90AA1—Metabolism—GSTM1—atherosclerosis	8.38e-05	0.000251	CbGpPWpGaD
Rifabutin—HSP90AA1—Immune System—ICAM1—atherosclerosis	8.38e-05	0.00025	CbGpPWpGaD
Rifabutin—HSP90AA1—Signaling Pathways—AGTR1—atherosclerosis	8.36e-05	0.00025	CbGpPWpGaD
Rifabutin—CYP1A2—Metabolism of lipids and lipoproteins—ABCG5—atherosclerosis	8.3e-05	0.000248	CbGpPWpGaD
Rifabutin—HSP90AA1—Disease—APOE—atherosclerosis	8.23e-05	0.000246	CbGpPWpGaD
Rifabutin—HSP90AA1—Metabolism—LPL—atherosclerosis	8.23e-05	0.000246	CbGpPWpGaD
Rifabutin—HSP90AA1—Cell Cycle—MAPK3—atherosclerosis	8.19e-05	0.000245	CbGpPWpGaD
Rifabutin—HSP90AA1—Disease—CAV1—atherosclerosis	8.16e-05	0.000244	CbGpPWpGaD
Rifabutin—HSP90AA1—Signaling Pathways—PLG—atherosclerosis	8.15e-05	0.000244	CbGpPWpGaD
Rifabutin—HSP90AA1—Disease—APOA1—atherosclerosis	8.14e-05	0.000243	CbGpPWpGaD
Rifabutin—HSP90AA1—Metabolism—GPX1—atherosclerosis	8.03e-05	0.00024	CbGpPWpGaD
Rifabutin—HSP90AA1—Developmental Biology—TNF—atherosclerosis	8.02e-05	0.00024	CbGpPWpGaD
Rifabutin—CYP1A2—Metabolism of lipids and lipoproteins—LPA—atherosclerosis	8.01e-05	0.00024	CbGpPWpGaD
Rifabutin—CYP3A4—Biological oxidations—GSTM1—atherosclerosis	7.95e-05	0.000238	CbGpPWpGaD
Rifabutin—HSP90B1—Immune System—AKT1—atherosclerosis	7.87e-05	0.000235	CbGpPWpGaD
Rifabutin—CYP3A4—Metapathway biotransformation—GSTM1—atherosclerosis	7.85e-05	0.000235	CbGpPWpGaD
Rifabutin—HSP90AA1—Innate Immune System—MAPK3—atherosclerosis	7.82e-05	0.000234	CbGpPWpGaD
Rifabutin—HSP90AA1—Metabolism—CD36—atherosclerosis	7.82e-05	0.000234	CbGpPWpGaD
Rifabutin—HSP90AA1—Signaling Pathways—SOCS3—atherosclerosis	7.72e-05	0.000231	CbGpPWpGaD
Rifabutin—CYP1A2—Metabolism of lipids and lipoproteins—APOA5—atherosclerosis	7.68e-05	0.00023	CbGpPWpGaD
Rifabutin—HSP90AA1—Disease—NOS2—atherosclerosis	7.67e-05	0.000229	CbGpPWpGaD
Rifabutin—HSP90AA1—Signaling Pathways—MMP3—atherosclerosis	7.45e-05	0.000223	CbGpPWpGaD
Rifabutin—HSP90AA1—Signaling Pathways—IGF2—atherosclerosis	7.42e-05	0.000222	CbGpPWpGaD
Rifabutin—HSP90AA1—Metabolism—MTHFR—atherosclerosis	7.41e-05	0.000221	CbGpPWpGaD
Rifabutin—CYP1A2—Metabolism of lipids and lipoproteins—PLA2G1B—atherosclerosis	7.4e-05	0.000221	CbGpPWpGaD
Rifabutin—CYP1A2—Metabolism—LDLRAP1—atherosclerosis	7.31e-05	0.000218	CbGpPWpGaD
Rifabutin—HSP90AA1—Metabolism—PPARA—atherosclerosis	7.27e-05	0.000217	CbGpPWpGaD
Rifabutin—HSP90AA1—Signaling Pathways—APOB—atherosclerosis	7.2e-05	0.000215	CbGpPWpGaD
Rifabutin—CYP1A2—Metabolism of lipids and lipoproteins—ALOX5—atherosclerosis	7.14e-05	0.000214	CbGpPWpGaD
Rifabutin—HSP90AA1—Signaling Pathways—EDN1—atherosclerosis	7.09e-05	0.000212	CbGpPWpGaD
Rifabutin—HSP90AA1—Metabolism—AGT—atherosclerosis	7.04e-05	0.00021	CbGpPWpGaD
Rifabutin—HSP90AA1—Signaling Pathways—CCL5—atherosclerosis	7.03e-05	0.00021	CbGpPWpGaD
Rifabutin—HSP90AA1—Disease—INS—atherosclerosis	7.03e-05	0.00021	CbGpPWpGaD
Rifabutin—HSP90AA1—Metabolism—APOE—atherosclerosis	6.9e-05	0.000206	CbGpPWpGaD
Rifabutin—HSP90AA1—Signaling Pathways—LPL—atherosclerosis	6.88e-05	0.000206	CbGpPWpGaD
Rifabutin—CYP1A2—Metabolism—PLTP—atherosclerosis	6.87e-05	0.000205	CbGpPWpGaD
Rifabutin—HSP90AA1—Metabolism—CAV1—atherosclerosis	6.83e-05	0.000204	CbGpPWpGaD
Rifabutin—HSP90AA1—Metabolism—APOA1—atherosclerosis	6.82e-05	0.000204	CbGpPWpGaD
Rifabutin—HSP90AA1—Signaling Pathways—PRKCG—atherosclerosis	6.69e-05	0.0002	CbGpPWpGaD
Rifabutin—HSP90AA1—Signaling Pathways—SPP1—atherosclerosis	6.51e-05	0.000195	CbGpPWpGaD
Rifabutin—HSP90AA1—Developmental Biology—IL6—atherosclerosis	6.47e-05	0.000193	CbGpPWpGaD
Rifabutin—HSP90AA1—Disease—SERPINE1—atherosclerosis	6.46e-05	0.000193	CbGpPWpGaD
Rifabutin—HSP90AA1—Immune System—IFNG—atherosclerosis	6.37e-05	0.000191	CbGpPWpGaD
Rifabutin—CYP1A2—Metabolism of lipids and lipoproteins—LIPC—atherosclerosis	6.37e-05	0.00019	CbGpPWpGaD
Rifabutin—CYP1A2—Metabolism of lipids and lipoproteins—APOC3—atherosclerosis	6.33e-05	0.000189	CbGpPWpGaD
Rifabutin—CYP1A2—Metabolism of lipids and lipoproteins—LDLR—atherosclerosis	6.29e-05	0.000188	CbGpPWpGaD
Rifabutin—HSP90AA1—Metabolism—PIK3CG—atherosclerosis	6.22e-05	0.000186	CbGpPWpGaD
Rifabutin—HSP90AA1—Disease—NOS3—atherosclerosis	6.17e-05	0.000184	CbGpPWpGaD
Rifabutin—CYP1A2—Metabolism of lipids and lipoproteins—CETP—atherosclerosis	6.14e-05	0.000184	CbGpPWpGaD
Rifabutin—HSP90AA1—Signaling Pathways—PDGFB—atherosclerosis	6.03e-05	0.00018	CbGpPWpGaD
Rifabutin—HSP90AA1—Metabolism—PPARG—atherosclerosis	6.01e-05	0.00018	CbGpPWpGaD
Rifabutin—HSP90AA1—Developmental Biology—AKT1—atherosclerosis	5.97e-05	0.000178	CbGpPWpGaD
Rifabutin—CYP1A2—Metabolism—LTA4H—atherosclerosis	5.96e-05	0.000178	CbGpPWpGaD
Rifabutin—CYP1A2—Metabolism—ABCG8—atherosclerosis	5.96e-05	0.000178	CbGpPWpGaD
Rifabutin—HSP90AA1—Metabolism—INS—atherosclerosis	5.89e-05	0.000176	CbGpPWpGaD
Rifabutin—HSP90AA1—Signaling Pathways—AGT—atherosclerosis	5.88e-05	0.000176	CbGpPWpGaD
Rifabutin—CYP1A2—Metabolism of lipids and lipoproteins—SCARB1—atherosclerosis	5.88e-05	0.000176	CbGpPWpGaD
Rifabutin—HSP90AA1—Signaling Pathways—APOE—atherosclerosis	5.77e-05	0.000172	CbGpPWpGaD
Rifabutin—HSP90AA1—Signaling Pathways—LEP—atherosclerosis	5.77e-05	0.000172	CbGpPWpGaD
Rifabutin—HSP90AA1—Innate Immune System—IL6—atherosclerosis	5.72e-05	0.000171	CbGpPWpGaD
Rifabutin—HSP90AA1—Signaling Pathways—CAV1—atherosclerosis	5.71e-05	0.000171	CbGpPWpGaD
Rifabutin—HSP90AA1—Signaling Pathways—APOA1—atherosclerosis	5.7e-05	0.00017	CbGpPWpGaD
Rifabutin—HSP90AA1—Immune System—IL1B—atherosclerosis	5.68e-05	0.00017	CbGpPWpGaD
Rifabutin—HSP90AA1—Disease—PTGS2—atherosclerosis	5.64e-05	0.000169	CbGpPWpGaD
Rifabutin—CYP3A4—Metabolism—LDLRAP1—atherosclerosis	5.64e-05	0.000169	CbGpPWpGaD
Rifabutin—CYP1A2—Metabolism of lipids and lipoproteins—HMGCR—atherosclerosis	5.55e-05	0.000166	CbGpPWpGaD
Rifabutin—HSP90AA1—Signaling Pathways—ESR1—atherosclerosis	5.5e-05	0.000165	CbGpPWpGaD
Rifabutin—HSP90AA1—Signaling Pathways—F2—atherosclerosis	5.44e-05	0.000163	CbGpPWpGaD
Rifabutin—HSP90AA1—Metabolism—ALB—atherosclerosis	5.4e-05	0.000161	CbGpPWpGaD
Rifabutin—HSP90AA1—Immune System—NFKB1—atherosclerosis	5.3e-05	0.000159	CbGpPWpGaD
Rifabutin—CYP3A4—Metabolism—PLTP—atherosclerosis	5.3e-05	0.000159	CbGpPWpGaD
Rifabutin—HSP90AA1—Innate Immune System—AKT1—atherosclerosis	5.27e-05	0.000158	CbGpPWpGaD
Rifabutin—HSP90AA1—Immune System—MAPK8—atherosclerosis	5.21e-05	0.000156	CbGpPWpGaD
Rifabutin—HSP90AA1—Signaling Pathways—PIK3CG—atherosclerosis	5.2e-05	0.000156	CbGpPWpGaD
Rifabutin—HSP90AA1—Metabolism—NOS3—atherosclerosis	5.17e-05	0.000154	CbGpPWpGaD
Rifabutin—CYP1A2—Metabolism of lipids and lipoproteins—ABCA1—atherosclerosis	4.95e-05	0.000148	CbGpPWpGaD
Rifabutin—HSP90AA1—Signaling Pathways—INS—atherosclerosis	4.93e-05	0.000147	CbGpPWpGaD
Rifabutin—HSP90AA1—Signaling Pathways—CCL2—atherosclerosis	4.85e-05	0.000145	CbGpPWpGaD
Rifabutin—HSP90AA1—Immune System—STAT3—atherosclerosis	4.77e-05	0.000142	CbGpPWpGaD
Rifabutin—HSP90AA1—Signaling Pathways—IGF1—atherosclerosis	4.76e-05	0.000142	CbGpPWpGaD
Rifabutin—HSP90AA1—Metabolism—PTGS2—atherosclerosis	4.72e-05	0.000141	CbGpPWpGaD
Rifabutin—CYP1A2—Metabolism—ABCG1—atherosclerosis	4.71e-05	0.000141	CbGpPWpGaD
Rifabutin—CYP3A4—Metabolism—ABCG8—atherosclerosis	4.6e-05	0.000137	CbGpPWpGaD
Rifabutin—CYP3A4—Metabolism—LTA4H—atherosclerosis	4.6e-05	0.000137	CbGpPWpGaD
Rifabutin—HSP90AA1—Immune System—MAPK3—atherosclerosis	4.55e-05	0.000136	CbGpPWpGaD
Rifabutin—HSP90AA1—Signaling Pathways—SERPINE1—atherosclerosis	4.52e-05	0.000135	CbGpPWpGaD
Rifabutin—CYP1A2—Metabolism—LCAT—atherosclerosis	4.43e-05	0.000132	CbGpPWpGaD
Rifabutin—CYP1A2—Metabolism—FABP4—atherosclerosis	4.43e-05	0.000132	CbGpPWpGaD
Rifabutin—HSP90AA1—Disease—STAT3—atherosclerosis	4.4e-05	0.000132	CbGpPWpGaD
Rifabutin—CYP1A2—Metabolism—APOA4—atherosclerosis	4.35e-05	0.00013	CbGpPWpGaD
Rifabutin—HSP90AA1—Signaling Pathways—NOS3—atherosclerosis	4.32e-05	0.000129	CbGpPWpGaD
Rifabutin—CYP1A2—Metabolism—CYP7A1—atherosclerosis	4.27e-05	0.000128	CbGpPWpGaD
Rifabutin—HSP90AA1—Disease—MAPK3—atherosclerosis	4.2e-05	0.000126	CbGpPWpGaD
Rifabutin—HSP90AA1—Disease—TGFB1—atherosclerosis	4.08e-05	0.000122	CbGpPWpGaD
Rifabutin—CYP1A2—Metabolism of lipids and lipoproteins—APOB—atherosclerosis	4.07e-05	0.000122	CbGpPWpGaD
Rifabutin—CYP1A2—Metabolism—CYP27A1—atherosclerosis	3.95e-05	0.000118	CbGpPWpGaD
Rifabutin—CYP1A2—Metabolism of lipids and lipoproteins—LPL—atherosclerosis	3.89e-05	0.000116	CbGpPWpGaD
Rifabutin—HSP90AA1—Signaling Pathways—CXCL8—atherosclerosis	3.83e-05	0.000115	CbGpPWpGaD
Rifabutin—CYP1A2—Metabolism of lipids and lipoproteins—GPX1—atherosclerosis	3.79e-05	0.000113	CbGpPWpGaD
Rifabutin—CYP1A2—Metabolism—PLA2G2A—atherosclerosis	3.74e-05	0.000112	CbGpPWpGaD
Rifabutin—CYP1A2—Metabolism—APOA2—atherosclerosis	3.74e-05	0.000112	CbGpPWpGaD
Rifabutin—CYP1A2—Metabolism—ALOX15—atherosclerosis	3.74e-05	0.000112	CbGpPWpGaD
Rifabutin—CYP1A2—Metabolism—ALOX5AP—atherosclerosis	3.74e-05	0.000112	CbGpPWpGaD
Rifabutin—CYP1A2—Metabolism—ABCG5—atherosclerosis	3.7e-05	0.00011	CbGpPWpGaD
Rifabutin—CYP1A2—Metabolism of lipids and lipoproteins—CD36—atherosclerosis	3.69e-05	0.00011	CbGpPWpGaD
Rifabutin—CYP3A4—Metabolism—ABCG1—atherosclerosis	3.63e-05	0.000109	CbGpPWpGaD
Rifabutin—CYP1A2—Metabolism—LPA—atherosclerosis	3.57e-05	0.000107	CbGpPWpGaD
Rifabutin—HSP90AA1—Signaling Pathways—MMP9—atherosclerosis	3.47e-05	0.000104	CbGpPWpGaD
Rifabutin—CYP1A2—Metabolism—BGN—atherosclerosis	3.46e-05	0.000103	CbGpPWpGaD
Rifabutin—CYP1A2—Metabolism of lipids and lipoproteins—PPARA—atherosclerosis	3.43e-05	0.000103	CbGpPWpGaD
Rifabutin—HSP90AA1—Signaling Pathways—NFKB1—atherosclerosis	3.43e-05	0.000102	CbGpPWpGaD
Rifabutin—CYP1A2—Metabolism—APOA5—atherosclerosis	3.42e-05	0.000102	CbGpPWpGaD
Rifabutin—CYP3A4—Metabolism—FABP4—atherosclerosis	3.42e-05	0.000102	CbGpPWpGaD
Rifabutin—CYP3A4—Metabolism—LCAT—atherosclerosis	3.42e-05	0.000102	CbGpPWpGaD
Rifabutin—HSP90AA1—Signaling Pathways—MAPK8—atherosclerosis	3.37e-05	0.000101	CbGpPWpGaD
Rifabutin—CYP3A4—Metabolism—APOA4—atherosclerosis	3.35e-05	0.0001	CbGpPWpGaD
Rifabutin—HSP90AA1—Immune System—IL6—atherosclerosis	3.33e-05	9.95e-05	CbGpPWpGaD
Rifabutin—CYP1A2—Metabolism of lipids and lipoproteins—AGT—atherosclerosis	3.32e-05	9.94e-05	CbGpPWpGaD
Rifabutin—CYP3A4—Metabolism—CYP7A1—atherosclerosis	3.3e-05	9.85e-05	CbGpPWpGaD
Rifabutin—CYP1A2—Metabolism—PLA2G1B—atherosclerosis	3.29e-05	9.85e-05	CbGpPWpGaD
Rifabutin—CYP1A2—Metabolism of lipids and lipoproteins—APOE—atherosclerosis	3.26e-05	9.73e-05	CbGpPWpGaD
Rifabutin—CYP1A2—Metabolism of lipids and lipoproteins—CAV1—atherosclerosis	3.23e-05	9.65e-05	CbGpPWpGaD
Rifabutin—CYP1A2—Metabolism of lipids and lipoproteins—APOA1—atherosclerosis	3.22e-05	9.62e-05	CbGpPWpGaD
Rifabutin—CYP1A2—Metabolism—ALOX5—atherosclerosis	3.18e-05	9.51e-05	CbGpPWpGaD
Rifabutin—HSP90AA1—Signaling Pathways—VEGFA—atherosclerosis	3.11e-05	9.3e-05	CbGpPWpGaD
Rifabutin—HSP90AA1—Signaling Pathways—STAT3—atherosclerosis	3.08e-05	9.21e-05	CbGpPWpGaD
Rifabutin—HSP90AA1—Disease—IL6—atherosclerosis	3.07e-05	9.19e-05	CbGpPWpGaD
Rifabutin—HSP90AA1—Immune System—AKT1—atherosclerosis	3.07e-05	9.18e-05	CbGpPWpGaD
Rifabutin—CYP3A4—Metabolism—CYP27A1—atherosclerosis	3.05e-05	9.1e-05	CbGpPWpGaD
Rifabutin—HSP90AA1—Signaling Pathways—MAPK3—atherosclerosis	2.94e-05	8.8e-05	CbGpPWpGaD
Rifabutin—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CG—atherosclerosis	2.94e-05	8.79e-05	CbGpPWpGaD
Rifabutin—CYP3A4—Metabolism—APOA2—atherosclerosis	2.89e-05	8.63e-05	CbGpPWpGaD
Rifabutin—CYP3A4—Metabolism—ALOX15—atherosclerosis	2.89e-05	8.63e-05	CbGpPWpGaD
Rifabutin—CYP3A4—Metabolism—PLA2G2A—atherosclerosis	2.89e-05	8.63e-05	CbGpPWpGaD
Rifabutin—CYP3A4—Metabolism—ALOX5AP—atherosclerosis	2.89e-05	8.63e-05	CbGpPWpGaD
Rifabutin—HSP90AA1—Signaling Pathways—TGFB1—atherosclerosis	2.86e-05	8.54e-05	CbGpPWpGaD
Rifabutin—CYP1A2—Metabolism—NAMPT—atherosclerosis	2.85e-05	8.53e-05	CbGpPWpGaD
Rifabutin—CYP3A4—Metabolism—ABCG5—atherosclerosis	2.85e-05	8.53e-05	CbGpPWpGaD
Rifabutin—CYP1A2—Metabolism of lipids and lipoproteins—PPARG—atherosclerosis	2.84e-05	8.48e-05	CbGpPWpGaD
Rifabutin—HSP90AA1—Disease—AKT1—atherosclerosis	2.84e-05	8.48e-05	CbGpPWpGaD
Rifabutin—CYP1A2—Metabolism—LIPC—atherosclerosis	2.84e-05	8.48e-05	CbGpPWpGaD
Rifabutin—CYP1A2—Metabolism—APOC3—atherosclerosis	2.82e-05	8.42e-05	CbGpPWpGaD
Rifabutin—CYP1A2—Metabolism—LDLR—atherosclerosis	2.8e-05	8.37e-05	CbGpPWpGaD
Rifabutin—CYP3A4—Metabolism—LPA—atherosclerosis	2.75e-05	8.23e-05	CbGpPWpGaD
Rifabutin—CYP1A2—Metabolism—CETP—atherosclerosis	2.74e-05	8.18e-05	CbGpPWpGaD
Rifabutin—CYP3A4—Metabolism—BGN—atherosclerosis	2.67e-05	7.97e-05	CbGpPWpGaD
Rifabutin—CYP3A4—Metabolism—APOA5—atherosclerosis	2.64e-05	7.89e-05	CbGpPWpGaD
Rifabutin—CYP1A2—Metabolism—SCARB1—atherosclerosis	2.62e-05	7.83e-05	CbGpPWpGaD
Rifabutin—CYP1A2—Metabolism of lipids and lipoproteins—ALB—atherosclerosis	2.55e-05	7.62e-05	CbGpPWpGaD
Rifabutin—CYP3A4—Metabolism—PLA2G1B—atherosclerosis	2.54e-05	7.6e-05	CbGpPWpGaD
Rifabutin—CYP1A2—Metabolism—HMGCR—atherosclerosis	2.47e-05	7.4e-05	CbGpPWpGaD
Rifabutin—CYP3A4—Metabolism—ALOX5—atherosclerosis	2.46e-05	7.34e-05	CbGpPWpGaD
Rifabutin—HSP90AA1—Metabolism—AKT1—atherosclerosis	2.37e-05	7.1e-05	CbGpPWpGaD
Rifabutin—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—atherosclerosis	2.23e-05	6.67e-05	CbGpPWpGaD
Rifabutin—CYP1A2—Metabolism—ABCA1—atherosclerosis	2.2e-05	6.59e-05	CbGpPWpGaD
Rifabutin—CYP3A4—Metabolism—NAMPT—atherosclerosis	2.2e-05	6.58e-05	CbGpPWpGaD
Rifabutin—CYP3A4—Metabolism—LIPC—atherosclerosis	2.19e-05	6.54e-05	CbGpPWpGaD
Rifabutin—CYP3A4—Metabolism—APOC3—atherosclerosis	2.17e-05	6.5e-05	CbGpPWpGaD
Rifabutin—CYP3A4—Metabolism—LDLR—atherosclerosis	2.16e-05	6.46e-05	CbGpPWpGaD
Rifabutin—HSP90AA1—Signaling Pathways—IL6—atherosclerosis	2.15e-05	6.43e-05	CbGpPWpGaD
Rifabutin—CYP3A4—Metabolism—CETP—atherosclerosis	2.11e-05	6.31e-05	CbGpPWpGaD
Rifabutin—CYP3A4—Metabolism—SCARB1—atherosclerosis	2.02e-05	6.04e-05	CbGpPWpGaD
Rifabutin—HSP90AA1—Signaling Pathways—AKT1—atherosclerosis	1.99e-05	5.94e-05	CbGpPWpGaD
Rifabutin—CYP3A4—Metabolism—HMGCR—atherosclerosis	1.91e-05	5.71e-05	CbGpPWpGaD
Rifabutin—CYP1A2—Metabolism—HMOX1—atherosclerosis	1.89e-05	5.66e-05	CbGpPWpGaD
Rifabutin—CYP1A2—Metabolism—APOB—atherosclerosis	1.81e-05	5.42e-05	CbGpPWpGaD
Rifabutin—CYP1A2—Metabolism—GSTM1—atherosclerosis	1.76e-05	5.27e-05	CbGpPWpGaD
Rifabutin—CYP1A2—Metabolism—LPL—atherosclerosis	1.73e-05	5.17e-05	CbGpPWpGaD
Rifabutin—CYP3A4—Metabolism—ABCA1—atherosclerosis	1.7e-05	5.09e-05	CbGpPWpGaD
Rifabutin—CYP1A2—Metabolism—GPX1—atherosclerosis	1.69e-05	5.05e-05	CbGpPWpGaD
Rifabutin—CYP1A2—Metabolism—CD36—atherosclerosis	1.64e-05	4.91e-05	CbGpPWpGaD
Rifabutin—CYP1A2—Metabolism—MTHFR—atherosclerosis	1.56e-05	4.66e-05	CbGpPWpGaD
Rifabutin—CYP1A2—Metabolism—PPARA—atherosclerosis	1.53e-05	4.57e-05	CbGpPWpGaD
Rifabutin—CYP1A2—Metabolism—AGT—atherosclerosis	1.48e-05	4.42e-05	CbGpPWpGaD
Rifabutin—CYP3A4—Metabolism—HMOX1—atherosclerosis	1.46e-05	4.36e-05	CbGpPWpGaD
Rifabutin—CYP1A2—Metabolism—APOE—atherosclerosis	1.45e-05	4.34e-05	CbGpPWpGaD
Rifabutin—CYP1A2—Metabolism—CAV1—atherosclerosis	1.44e-05	4.3e-05	CbGpPWpGaD
Rifabutin—CYP1A2—Metabolism—APOA1—atherosclerosis	1.43e-05	4.29e-05	CbGpPWpGaD
Rifabutin—CYP3A4—Metabolism—APOB—atherosclerosis	1.4e-05	4.18e-05	CbGpPWpGaD
Rifabutin—CYP3A4—Metabolism—GSTM1—atherosclerosis	1.36e-05	4.07e-05	CbGpPWpGaD
Rifabutin—CYP3A4—Metabolism—LPL—atherosclerosis	1.34e-05	3.99e-05	CbGpPWpGaD
Rifabutin—CYP1A2—Metabolism—PIK3CG—atherosclerosis	1.31e-05	3.91e-05	CbGpPWpGaD
Rifabutin—CYP3A4—Metabolism—GPX1—atherosclerosis	1.3e-05	3.89e-05	CbGpPWpGaD
Rifabutin—CYP3A4—Metabolism—CD36—atherosclerosis	1.27e-05	3.79e-05	CbGpPWpGaD
Rifabutin—CYP1A2—Metabolism—PPARG—atherosclerosis	1.26e-05	3.78e-05	CbGpPWpGaD
Rifabutin—CYP1A2—Metabolism—INS—atherosclerosis	1.24e-05	3.7e-05	CbGpPWpGaD
Rifabutin—CYP3A4—Metabolism—MTHFR—atherosclerosis	1.2e-05	3.59e-05	CbGpPWpGaD
Rifabutin—CYP3A4—Metabolism—PPARA—atherosclerosis	1.18e-05	3.53e-05	CbGpPWpGaD
Rifabutin—CYP3A4—Metabolism—AGT—atherosclerosis	1.14e-05	3.41e-05	CbGpPWpGaD
Rifabutin—CYP1A2—Metabolism—ALB—atherosclerosis	1.14e-05	3.4e-05	CbGpPWpGaD
Rifabutin—CYP3A4—Metabolism—APOE—atherosclerosis	1.12e-05	3.35e-05	CbGpPWpGaD
Rifabutin—CYP3A4—Metabolism—CAV1—atherosclerosis	1.11e-05	3.32e-05	CbGpPWpGaD
Rifabutin—CYP3A4—Metabolism—APOA1—atherosclerosis	1.11e-05	3.31e-05	CbGpPWpGaD
Rifabutin—CYP1A2—Metabolism—NOS3—atherosclerosis	1.09e-05	3.25e-05	CbGpPWpGaD
Rifabutin—CYP3A4—Metabolism—PIK3CG—atherosclerosis	1.01e-05	3.02e-05	CbGpPWpGaD
Rifabutin—CYP1A2—Metabolism—PTGS2—atherosclerosis	9.94e-06	2.97e-05	CbGpPWpGaD
Rifabutin—CYP3A4—Metabolism—PPARG—atherosclerosis	9.75e-06	2.91e-05	CbGpPWpGaD
Rifabutin—CYP3A4—Metabolism—INS—atherosclerosis	9.56e-06	2.86e-05	CbGpPWpGaD
Rifabutin—CYP3A4—Metabolism—ALB—atherosclerosis	8.77e-06	2.62e-05	CbGpPWpGaD
Rifabutin—CYP3A4—Metabolism—NOS3—atherosclerosis	8.39e-06	2.51e-05	CbGpPWpGaD
Rifabutin—CYP3A4—Metabolism—PTGS2—atherosclerosis	7.67e-06	2.29e-05	CbGpPWpGaD
Rifabutin—CYP1A2—Metabolism—AKT1—atherosclerosis	4.99e-06	1.49e-05	CbGpPWpGaD
Rifabutin—CYP3A4—Metabolism—AKT1—atherosclerosis	3.85e-06	1.15e-05	CbGpPWpGaD
